Elämäntapamuutoksen toimeenpanotutkimusverkosto PRC:ssä UMass Chanissa (LCIRN)
Elämäntapamuutosten toimeenpanotutkimusverkosto PRC:ssä UMass Chanissa
The goal of this project is to study how well the Noom digital lifestyle program works for adults who are taking Glucagon-Like Peptide-1 receptor agonist (GLP-1) medications. The study team will assess how the program affects people's behaviors and health outcomes. The team will also look at how digital lifestyle change interventions can be implemented in real-world settings, including how many people it reaches, how well it is put into practice, whether people stick with it over time, and whether it works well for different groups of people.
Tutkimuksen yleiskatsaus
Yksityiskohtainen kuvaus
This study will examine how a digital lifestyle change program (Noom) may support adults who have recently started taking GLP-1 medications, which are commonly prescribed for weight loss and blood sugar control. The goal is to better understand how structured lifestyle guidance may improve physical activity, nutrition, and overall health while people are using these medications.
A total of 220 adults will participate in the study. Participants will be randomly assigned to one of two groups. One group will receive a four-month digital lifestyle coaching program designed to support healthy eating, physical activity, and strength-building habits. The other group will receive standard of care, a Fitbit device, resources for physical activity and nutrition, and the opportunity to participate in the lifestyle program at the completion of their 8-months in the study.
Participants will be assessed at the start of the study, after four months, and again at eight months. Throughout the study, the team will measure levels of physical activity using Fitbit devices. They will also evaluate overall diet quality using 24- hour dietary recalls of foods and beverages consumed. In addition, the team will examine other health and behavior measures, including intake of protein, fruits, and vegetables; participation in muscle-strengthening activities; confidence in maintaining healthy habits; muscle mass; body weight; waist circumference; and blood pressure.
In the 2nd Aim, the study team will evaluate implementation factors, such as how many participants were reached, how the program was implemented, engagement within the program, and how well how well the lifestyle coaching program can be delivered within real-world healthcare settings. Information will be gathered from patients, lifestyle change program leaders, healthcare providers, and healthcare systems. Data sources will include medical records, program records, and interviews.
Opintotyyppi
Ilmoittautuminen (Arvioitu)
Vaihe
- Ei sovellettavissa
Yhteystiedot ja paikat
Opiskeluyhteys
- Nimi: Reem Y Najjar, BS
- Puhelinnumero: 774-275-0890
- Sähköposti: Reem.Najjar@umassmed.edu
Tutki yhteystietojen varmuuskopiointi
- Nimi: Joann Wagner, MSW
- Puhelinnumero: 508-856-6944
- Sähköposti: joann.wagner@umassmed.edu
Opiskelupaikat
-
-
Massachusetts
-
Worcester, Massachusetts, Yhdysvallat, 01605
- Rekrytointi
- UMass Chan Medical School - Shaw Building
-
Ottaa yhteyttä:
- Jamie Faro, PhD
- Puhelinnumero: 617-828-8093
- Sähköposti: jamie.faro@umassmed.edu
-
-
Osallistumiskriteerit
Kelpoisuusvaatimukset
Opintokelpoiset iät
Hyväksyy terveitä vapaaehtoisia
Sukupuolet, jotka voivat opiskella
Kuvaus
Inclusion Criteria:
- Began using a GLP-1 within the past 6 months
- Currently using GLP-1
- Plans to continue GLP-1 use
- GLP-1 prescribed by their physician (e.g., not online or 3rd party vendor)
- BMI ≥27 kg/m2
- Age 18 years of age and older
- Speaks and reads English or Spanish
- Willing to enroll in a digital lifestyle intervention for 4-months
- Willing to wear a Fitbit for 8 months
Exclusion Criteria:
- Was taking a GLP-1 within the 2 months prior to the current GLP-1 start date
- Currently participating in a structured lifestyle change program (receiving structured guidance and counseling on physical activity, diet or weight loss)
- Currently pregnant
- Planning to become pregnant in the next year
- Active diagnosis of an eating disorder
- Active diagnosis of Schizophrenia or bipolar disorder
- Unable to walk without assistance/assistive device or have restricted walking
- Inability to understand the study and provide informed consent
- Any physical, cognitive, or psychiatric condition that poses a risk or interferes with their ability to participate at the discretion of the study PI (Co-Is: in consultation with PI or if acting as/standing in for PI)
Opintosuunnitelma
Miten tutkimus on suunniteltu?
Suunnittelun yksityiskohdat
- Ensisijainen käyttötarkoitus: Tukevaa hoitoa
- Jako: Satunnaistettu
- Inventiomalli: Rinnakkaistehtävä
- Naamiointi: Ei mitään (avoin tarra)
Aseet ja interventiot
Osallistujaryhmä / Arm |
Interventio / Hoito |
|---|---|
|
Kokeellinen: Digital Lifestyle Coaching Program
Participants randomized to the digital LCI arm will participate in a 4-month digital lifestyle intervention consisting of content modules about physical activity, nutrition, and GLP-1 support, nutrition and physical activity tracking, goal-setting, access to a health coach. They will receive a Fitbit and the same resources as the Standard of Care arm. |
Participants will be enrolled for a 4-month program, in which they will use the Noom app to self-monitor their dietary intake/physical activity, be provided with coaching feedback throughout, and access educational module. Modules include behavior change specific to GLP-1, i.e. higher protein intake than what is prescribed in Noom Weight, Common challenges while taking GLP-1 medications, and weight loss medications and what to expect while taking them. They will also have access to the Muscle Defense program, which provides education on resistance training exercises to prevent muscle loss. |
|
Ei väliintuloa: Standard Care
Participants in the standard of care arm will receive physical activity and nutrition resources, including those endorsed by the CDC and local resources within UMass Memorial Health and the surrounding communities, as well as Fitbit device. Upon completion of the 8-month study measures, participants will have the opportunity to participate in the 4-month digital LCI program, free of cost. |
Mitä tutkimuksessa mitataan?
Ensisijaiset tulostoimenpiteet
Tulosmittaus |
Toimenpiteen kuvaus |
Aikaikkuna |
|---|---|---|
|
Primary Outcomes
Aikaikkuna: Baseline, 4-, and 8-months
|
Minutes of moderate/vigorous PA per day (over 7 days) assessed via Fitbits on days the participant has sufficient wear time, defined as >10 hours of heart rate data (accumulated of 60-second bouts). |
Baseline, 4-, and 8-months
|
|
Healthy Eating Index
Aikaikkuna: Baseline, 4, and 8 months
|
Healthy Eating Index will be assessed via two 24-hour dietary recalls at each timepoint. The Healthy Eating Index is scored on a scale 0-100, with higher scores indicating better diet quality and alignment with the Dietary Guidelines for Americans. |
Baseline, 4, and 8 months
|
Toissijaiset tulostoimenpiteet
Tulosmittaus |
Toimenpiteen kuvaus |
Aikaikkuna |
|---|---|---|
|
Physical Activity/Sedentary Time Metrics
Aikaikkuna: Mean counts over 7-days at baseline, 4-, and 8-months.
|
Objective metrics of mean step counts (steps/day), light physical activity (minutes/day), sedentary time (hours/day) over 7 days assessed via Fitbit Inspire using Fitbit algorithms and obtained through Fitabase. |
Mean counts over 7-days at baseline, 4-, and 8-months.
|
|
Protein, Fruit, and Vegetable Intake
Aikaikkuna: Baseline, 4-, and 8-months
|
Proportion of daily intake values for each category will be assessed using two 24-hour dietary recalls. |
Baseline, 4-, and 8-months
|
|
Lean Body Mass
Aikaikkuna: Baseline, 4-, and 8-months
|
Lean body mass will be assessed using a seca mBCA 554 bioelectrical impedance scale. The scale will obtain the results of the patient's body composition (% muscle mass, % water, % body fat, including areas of distribution). |
Baseline, 4-, and 8-months
|
|
Body Weight
Aikaikkuna: Baseline, 4-, and 8-months
|
Body weight will be assessed via a seca mBCA 554 bioelectrical impedance scale. |
Baseline, 4-, and 8-months
|
|
Blood Pressure
Aikaikkuna: Baseline, 4-, and 8-months
|
Three blood pressure readings will be taken 2 minutes apart after 5 minutes of rest using an automatic oscillometric device, Omron HEM-907. The average of the three readings will be recorded. |
Baseline, 4-, and 8-months
|
|
Body Mass Index (BMI)
Aikaikkuna: Baseline, 4-, and 8-months
|
Obtained via two height measurements using a stadiometer and one weight measurement using a Seca scale, using the standard equation (Weight (lbs) x 703) / height (in)2 |
Baseline, 4-, and 8-months
|
|
Muscle Strengthening Activities
Aikaikkuna: Baseline, 4-, and 8-months
|
Assessed via self-report using the Muscle Strengthening Exercise Questionnaire Short Form, a scale assessing key dimensions of muscle-strengthening exercise, including frequency, session duration, intensity, exercise type, and muscle groups targeted |
Baseline, 4-, and 8-months
|
|
Physical Activity Self-Efficacy
Aikaikkuna: Baseline, 4-, and 8-months
|
A self-report assessment using the Self-efficacy for Physical Activity Scale, a 5-question scale assessing how confident a person is that they could be physically active in certain situations |
Baseline, 4-, and 8-months
|
|
Physical Activity Motivation
Aikaikkuna: Baseline, 4-, and 8-months
|
A self-report assessment using the 1 question Readiness to Change for Physical Activity, which assess a person's current physical activity habits and readiness to change. |
Baseline, 4-, and 8-months
|
|
Healthy Eating Self-Efficacy
Aikaikkuna: Baseline, 4-, and 8-months
|
A self-report assessment using the Eating and Weight Self-efficacy Scale, a 7-question scale assessing a person's confidence to eat healthy in certain situations |
Baseline, 4-, and 8-months
|
|
Healthy Eating Motivation
Aikaikkuna: Baseline, 4-, and 8-months
|
A self-report assessment using the 1 question Readiness to Change for Healthy Eating, which assess a person's current eating habits and readiness to change |
Baseline, 4-, and 8-months
|
|
Global Physical Health
Aikaikkuna: Baseline, 4-, and 8-months
|
Physical health will be assessed using the PROMIS Global Physical Health, consisting of 4 questions asking about overall health, physical function, pain, and fatigue using Likert scale responses |
Baseline, 4-, and 8-months
|
|
Intervention Acceptability
Aikaikkuna: 4-months in Intervention group only
|
The Theoretical Framework of Acceptability (TFA) is an 8-item questionnaire that can be adapted to an intervention to assess the acceptability of healthcare interventions using a Likert scale of 1 to 5 (higher scores indicating greater acceptability). |
4-months in Intervention group only
|
Yhteistyökumppanit ja tutkijat
Tutkijat
- Päätutkija: Jamie Faro, PhD, UMass Chan Medical School
Opintojen ennätyspäivät
Opi tärkeimmät päivämäärät
Opiskelun aloitus (Todellinen)
Ensisijainen valmistuminen (Arvioitu)
Opintojen valmistuminen (Arvioitu)
Opintoihin ilmoittautumispäivät
Ensimmäinen lähetetty
Ensimmäinen toimitettu, joka täytti QC-kriteerit
Ensimmäinen Lähetetty (Todellinen)
Tutkimustietojen päivitykset
Viimeisin päivitys julkaistu (Todellinen)
Viimeisin lähetetty päivitys, joka täytti QC-kriteerit
Viimeksi vahvistettu
Lisää tietoa
Tähän tutkimukseen liittyvät termit
Avainsanat
Muita asiaankuuluvia MeSH-ehtoja
Muut tutkimustunnusnumerot
- STUDY00002809
- U48DP006955 (Yhdysvaltain NIH-apuraha/sopimus)
Yksittäisten osallistujien tietojen suunnitelma (IPD)
Aiotko jakaa yksittäisten osallistujien tietoja (IPD)?
IPD-suunnitelman kuvaus
Participant survey data and participant physiologic data will be shared. This includes a complete, de-identified data set, including survey and clinical/physiologic data (and relevant R or SAS code) through DKnet, the Inter-University Consortium for Political and Social Research, or eScholarship@UMassChan.
IPD-jaon aikakehys
IPD and supporting information will become available at time of primary results publication.
IPD-jakamista tukeva tietotyyppi
- STUDY_PROTOCOL
- MAHLA
- ICF
Lääke- ja laitetiedot, tutkimusasiakirjat
Tutkii yhdysvaltalaista FDA sääntelemää lääkevalmistetta
Tutkii yhdysvaltalaista FDA sääntelemää laitetuotetta
Nämä tiedot haettiin suoraan verkkosivustolta clinicaltrials.gov ilman muutoksia. Jos sinulla on pyyntöjä muuttaa, poistaa tai päivittää tutkimustietojasi, ota yhteyttä register@clinicaltrials.gov. Heti kun muutos on otettu käyttöön osoitteessa clinicaltrials.gov, se päivitetään automaattisesti myös verkkosivustollemme .